Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume 39, Issue 8, Pages 643-649
Publisher
Wiley
Online
2012-05-18
DOI
10.1111/j.1440-1681.2012.05724.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arginase inhibition alleviates hypertension associated with diabetes: Effect on endothelial dependent relaxation and NO production
- (2012) Hany M. El-Bassossy et al. VASCULAR PHARMACOLOGY
- Role of microRNAs in diabetes and its cardiovascular complications
- (2011) S. Shantikumar et al. CARDIOVASCULAR RESEARCH
- Cinnamaldehyde protects from the hypertension associated with diabetes
- (2011) Hany M. El-Bassossy et al. FOOD AND CHEMICAL TOXICOLOGY
- Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition
- (2011) Hany M. El-Bassossy et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Ginkgo biloba extract (EGb 761) normalizes hypertension in 2K, 1C hypertensive rats: Role of antioxidant mechanisms, ACE inhibiting activity and improvement of endothelial dysfunction
- (2011) Suzan M. Mansour et al. PHYTOMEDICINE
- Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function
- (2010) Mahmoud M. El-Mas et al. BIOCHEMICAL PHARMACOLOGY
- Angiotensin-(1–7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities
- (2010) Gursev S. Dhaunsi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Haem oxygenase-1 induction protects against tumour necrosis factor α impairment of endothelial-dependent relaxation in rat isolated pulmonary artery
- (2009) Hany M. El-Bassossy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats
- (2009) J. Eliza et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Rosiglitazone (peroxisome proliferator-activated receptor-gamma) counters hypertension and adverse cardiac and vascular remodeling in 2K1C hypertensive rats
- (2009) Geraldo de Oliveira Silva-Junior et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Impaired Coronary Microvascular Dilation Correlates with Enhanced Vascular Smooth Muscle MLC Phosphorylation in Diabetes1
- (2009) Richard T. Clements et al. MICROCIRCULATION
- Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta☆
- (2009) W.T. Wong et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress
- (2009) Ling-Bo Qian et al. PHARMACOLOGICAL RESEARCH
- Peroxisome Proliferator-Activated Receptor-γ–Mediated Effects in the Vasculature
- (2008) Sheng Zhong Duan et al. CIRCULATION RESEARCH
- Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Ligands: Novel Pharmacological Agents in the Treatment of Ischemia Reperfusion Injury
- (2008) Costas Giaginis et al. CURRENT MOLECULAR MEDICINE
- Effects of a Western diet versus high glucose on endothelium-dependent relaxation in murine micro- and macro-vasculature
- (2008) Anthie Ellis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride
- (2008) Mona Schaalan et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More